Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

Axcelead Drug Discovery Partners, Inc.

Year Established:
Fujisawa, Kanagawa, JP
Company Type:
Mid-Sized Business (10-100M TTM Revenue)

Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan.
Scope of Business: Providing advisory and research services on drug discovery, etc.
Axcelead offer a comprehensive set of best-in-class capabilities to meet a range of customer needs.
Capability: Screening (Hit finding, Lead generation/optimization, Compound library management), Chemistry (Medicinal Chemistry, Peotide chemistry, Synthetic chemistry, High-throughput synthesis, Analytical chemistry, Computational chemistry), Biology (Pharmacology studies in oncology, immunological disorders, central nervous system diseases, cardiovascular diseases metabolic diseases, gastrointestinal motility disorders, and cell therapy using large animals, Omics, Bioinformatics, Genetically modified animals (mics), DMPK (ADME screening, Discovery DMPK studies, Physicochemistry and preformulation, studies, Pre-clinical development), Safety (In vitro and in vivo exploratory safety studies, IND/NDA enabling, Toxicity mechanism studies/Target validation/Efficacy studies, Consulting services)

Site Badges
Axcelead Drug Discovery Partners, Inc.
Fujisawa, Kanagawa Prefecture, 251-0012 Japan
Axcelead Drug Discovery Partners, Inc.
26-1, Muraoka-Higashi 2-chome Fujisawa, Kanagawa, 2510012 Japan

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service